LOW DOSE VERSUS STANDARD DOSE INFUSION OF GEMCITABINE AND CISPLATIN IN ADVANCED NON- SMALL CELL LUNG CANCERLOW DOSE VERSUS STANDARD DOSE INFUSION OF GEMCITABINE AND CISPLATIN IN ADVANCED NON- SMALL CELL LUNG CANCER
Nervana Magdy Hussien;
Abstract
INTRODUCTION
L
ung cancer is the leading cause of cancer-related mortality in both men and women in the United States and throughout the world. The prevalence of lung cancer is second only to that of prostate cancer in men and breast cancer in women. Lung
L
ung cancer is the leading cause of cancer-related mortality in both men and women in the United States and throughout the world. The prevalence of lung cancer is second only to that of prostate cancer in men and breast cancer in women. Lung
Other data
| Title | LOW DOSE VERSUS STANDARD DOSE INFUSION OF GEMCITABINE AND CISPLATIN IN ADVANCED NON- SMALL CELL LUNG CANCERLOW DOSE VERSUS STANDARD DOSE INFUSION OF GEMCITABINE AND CISPLATIN IN ADVANCED NON- SMALL CELL LUNG CANCER | Other Titles | مقارنة بين الجرعة المنخفضة و الجرعة المعتادة للعلاج الكيمائى الجمسيتابين و السيسبلاتين فى علاج حالات سرطان الرئة المتقدمة | Authors | Nervana Magdy Hussien | Keywords | LOW DOSE VERSUS STANDARD DOSE INFUSION OF GEMCITABINE AND CISPLATIN IN ADVANCED NON- SMALL CELL LUNG CANCERLOW DOSE VERSUS STANDARD DOSE INFUSION OF GEMCITABINE AND CISPLATIN IN ADVANCED NON- SMALL CELL LUNG CANCER | Issue Date | 2011 | Description | INTRODUCTION L ung cancer is the leading cause of cancer-related mortality in both men and women in the United States and throughout the world. The prevalence of lung cancer is second only to that of prostate cancer in men and breast cancer in women. Lung |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| Binder1.pdf | 397.46 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.